| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Feb 6, 2025 | Tango Therapeutics, Inc. | Officer | Sell | 46.3 | -14,283 | -8.28% | ✗ | $43.9K |
| Feb 6, 2024 | Feb 8, 2024 | Tango Therapeutics, Inc. | Officer | Sell | 42.5 | -8,371 | -6.55% | ✗ | $105.4K |
| Nov 1, 2023 | Nov 2, 2023 | Tango Therapeutics, Inc. | Officer | Sell | 22.5 | -7,507 | -8.46% | ✗ | $63K |
| Jan 30, 2023 | Feb 1, 2023 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 46.3 | -1,301 | -6.08% | ✗ | $10.1K |
| May 26, 2022 | Jun 14, 2022 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 47.5 | -1,102 | -5.88% | ✗ | $7.7K |
| Jan 4, 2022 | Jan 5, 2022 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 7.5 | -15,000 | -50.00% | ✓ | $475K |
| Oct 1, 2021 | Oct 5, 2021 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 7.5 | -15,000 | -100.00% | ✓ | $681.4K |
| Jul 29, 2021 | Aug 2, 2021 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 7.5 | -15,000 | -100.00% | ✓ | $675K |
| Jul 1, 2021 | Jul 6, 2021 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 7.5 | -15,000 | -100.00% | ✓ | $569.7K |
| Apr 5, 2021 | Apr 6, 2021 | C4 Therapeutics, Inc. | Chief Medical Officer | Sell | 7.5 | -15,000 | -100.00% | ✓ | $566.5K |